Tag: Jing Chen
Proceed with caution
China's capital market faces tighter regulation, fewer new listings, and renewed interest in key international markets
Quartet guides HKD8.79bn privatisation bid for SciClone
Kirkland & Ellis, Clifford Chance, Sullivan & Cromwell and Slaughter and May advise on Silver Pegasus Investment's HKD8.79 billion take-private of SciClone Pharmaceuticals in Hong Kong
Three law firms advise Tencent Music’s homecoming listing on HKEX
Davis Polk, Han Kun Law Offices and Maples Group advised NYSE-listed Tencent Music Entertainment Group’s debut on the HKEX in a secondary listing by introduction
